-transparent.png){kind=logo}
The ability of gamma-hydroxybutyric acid to suppress ethanol withdrawal syndrome was tested in male rats rendered physically dependent on ethanol by several intragastric administrations of ethanol (9-15 g/kg daily for 7 days). Gamma-hydroxybutyrate (0.25, 0.50 and 1.00 g/kg i.p.), administered 8 hr after the last ethanol dose, produced a dose-dependent inhibition of withdrawal signs such as tremors and audiogenically-induced seizures; the highest dose tested suppressed all ethanol withdrawal symptoms.
Related Publications
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
March 1985,
European journal of pharmacology,
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
August 1993,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
September 1989,
Lancet (London, England),
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
July 2023,
Revue medicale de Liege,
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
July 2009,
Cases journal,
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
December 1976,
Science (New York, N.Y.),
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
February 1985,
Life sciences,
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
July 2021,
Cureus,
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
January 1998,
Alcohol and alcoholism (Oxford, Oxfordshire),
F Fadda, and
G Colombo, and
E Mosca, and
G L Gessa
May 1998,
Physiology & behavior,
